Lördag 10 Maj | 11:14:01 Europe / Stockholm

Bifogade filer

Kalender

Est. tid*
2025-08-22 15:20 Kvartalsrapport 2025-Q2
2025-06-03 N/A X-dag ordinarie utdelning S2M 0.00 SEK
2025-06-02 N/A Årsstämma
2025-02-21 - Bokslutskommuniké 2024
2024-11-15 - 15-10 2024-Q3
2024-08-23 - Kvartalsrapport 2024-Q2
2024-06-05 - X-dag ordinarie utdelning S2M 0.00 SEK
2024-06-04 - Årsstämma
2024-02-20 - Bokslutskommuniké 2023
2023-11-17 - Kvartalsrapport 2023-Q3
2023-08-25 - Kvartalsrapport 2023-Q2
2023-06-09 - X-dag ordinarie utdelning S2M 0.00 SEK
2023-06-08 - Årsstämma
2023-05-31 - Kvartalsrapport 2023-Q1
2023-02-22 - Bokslutskommuniké 2022
2022-11-11 - Kvartalsrapport 2022-Q3
2022-08-23 - Kvartalsrapport 2022-Q2
2022-06-02 - X-dag ordinarie utdelning S2M 0.00 SEK
2022-06-01 - Årsstämma
2022-05-17 - Kvartalsrapport 2022-Q1
2022-04-14 - Extra Bolagsstämma 2022
2022-02-18 - Bokslutskommuniké 2021
2021-12-30 - Extra Bolagsstämma 2021
2021-11-23 - Kvartalsrapport 2021-Q3
2021-08-23 - Kvartalsrapport 2021-Q2
2021-06-02 - X-dag ordinarie utdelning S2M 0.00 SEK
2021-06-01 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-03-05 - Bokslutskommuniké 2020
2020-11-23 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-06-12 - X-dag ordinarie utdelning S2M 0.00 SEK
2020-06-11 - Årsstämma
2020-05-22 - Kvartalsrapport 2020-Q1
2020-03-06 - Bokslutskommuniké 2019
2019-11-22 - Kvartalsrapport 2019-Q3
2019-08-23 - Kvartalsrapport 2019-Q2
2019-05-23 - Kvartalsrapport 2019-Q1
2019-05-17 - X-dag ordinarie utdelning S2M 0.00 SEK
2019-05-16 - Årsstämma
2019-03-06 - Bokslutskommuniké 2018

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
S2Medical är verksamt inom medicinteknik. Bolaget är inriktade mot forskning och utveckling av diverse sårläkningsprodukter. Olika produkter som erbjuds inkluderar cellulosabaserat material och förband för läkning av brännskador, samt kroniska sår. Produkterna säljs under olika varumärken, främst på europeisk nivå. S2Medical grundades under 2013 och har sitt huvudkontor i Linköping.
2023-04-21 15:37:06

S2Medical AB (publ) (the "Company") has, via the Company's local partner in the United Arab Emirates, won a procurement for wound healing items within Mubadala Health LLC. The value of the procurement is estimated at approximately SEK 1.7 million per year for at least 2 years, a total of approximately SEK 3.4 million. Mubadala Health has announced that they intend to call off the procurement quarterly with orders corresponding to approximately SEK 400,000 - 500,000.

Mubadala Health is part of the Mubadala Investment Company and is one of the UAE's largest healthcare providers. Mubadala Health owns, among others, Cleveland Clinic Abu Dhabi, Healthpoint, Imperial Collage London Diabetes Centre, Amana Healthcare and several other hospital chains in the country.

"Mubadala Healthcare represents healthcare providers who deliver world-class healthcare. Our customer offering fits perfectly with their approach and we are proud to now deliver wound healing products that will improve the care of patients suffering from various types of wounds. We look forward to becoming a long-term supplier and will share the knowledge that exists within the Company to not only deliver a product, but a complete solution for all types of wounds," says the Company's COO Mårten Skog.

This disclosure contains information that S2Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 21-04-2023 15:37 CET.